U.S. well being regulators are anticipated to weigh in quickly on the proof for giving the Covid-19 vaccine from Pfizer Inc. and BioNTech SE to youngsters 5 to 11 years outdated.
The businesses launched new knowledge Friday exhibiting the vaccine was 90.7% efficient at stopping symptomatic Covid-19 in a examine of youngsters on this age group, data that well being authorities will doubtless issue as they weigh whether or not to authorize the pictures to be used.
